These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4015182)

  • 21. Polymorphonuclear leukocyte chemotaxis in systemic lupus erythematosus.
    Perez HD; Goldstein IM
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():53-8. PubMed ID: 3612652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergism between zymosan-activated serum and heparin in the induction of polymorphonuclear leukocyte aggregation.
    Berliner S; Fishelson Z; Wasserman L; Pinkhas J; Aronson M
    Biomed Pharmacother; 1988; 42(1):69-72. PubMed ID: 3408808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complement activation and clearance in acute illness and injury: evidence for C5a as a cell-directed mediator of the adult respiratory distress syndrome in man.
    Solomkin JS; Cotta LA; Satoh PS; Hurst JM; Nelson RD
    Surgery; 1985 Jun; 97(6):668-78. PubMed ID: 4002115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific inhibitor of complement (C5)-derived chemotactic activity in systemic lupus erythematosus related antigenically to the Bb fragment of human factor B.
    Perez HD; Hooper C; Volanakis J; Ueda A
    J Immunol; 1987 Jul; 139(2):484-9. PubMed ID: 3648093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complement activation and stimulation of chemotaxis by Chlamydia trachomatis.
    Megran DW; Stiver HG; Bowie WR
    Infect Immun; 1985 Sep; 49(3):670-3. PubMed ID: 3940159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human C5a and C5a des Arg exhibit chemotactic activity for fibroblasts.
    Senior RM; Griffin GL; Perez HD; Webster RO
    J Immunol; 1988 Nov; 141(10):3570-4. PubMed ID: 3183381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of complement fragment C5a in milk is variable among cows.
    Rainard P; Poutrel B
    J Dairy Sci; 2000 May; 83(5):945-51. PubMed ID: 10821569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement levels in septic primates treated with anti-C5a antibodies.
    Hangen DH; Stevens JH; Satoh PS; Hall EW; O'Hanley PT; Raffin TA
    J Surg Res; 1989 Mar; 46(3):195-9. PubMed ID: 2493531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psoriasis and leukocyte chemotaxis.
    Tagami H; Iwatsuki K; Takematsu H
    J Invest Dermatol; 1987 Mar; 88(3 Suppl):18s-23s. PubMed ID: 3493302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leukocyte aggregation response to quantitative plasma levels of C3a and C5a.
    Williams JJ; Yellin SA; Slotman GJ
    Arch Surg; 1986 Mar; 121(3):305-7. PubMed ID: 3484946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the interaction of human C5a and C5a des Arg with human monocytes and neutrophils: flow cytometric and chemotaxis studies.
    Yancey KB; Lawley TJ; Dersookian M; Harvath L
    J Invest Dermatol; 1989 Feb; 92(2):184-9. PubMed ID: 2493055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C5 neoepitopes appearing during activation.
    Inoue K
    Complement Inflamm; 1989; 6(3):219-22. PubMed ID: 2472923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The release of C5a in complement-activated serum does not require C6.
    Biesecker G; Wagner JL; Hugli TE
    J Immunol; 1989 Aug; 143(4):1228-32. PubMed ID: 2545783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of neutrophil migratory function in burn injury by complement activation products.
    Solomkin JS; Nelson RD; Chenoweth DE; Solem LD; Simmons RL
    Ann Surg; 1984 Dec; 200(6):742-6. PubMed ID: 6508405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of chemotactic factors for neutrophils following the interaction of Bacteroides gingivalis with purified C5.
    Schenkein HA; Berry CR
    J Periodontal Res; 1988 Sep; 23(5):308-12. PubMed ID: 2974478
    [No Abstract]   [Full Text] [Related]  

  • 36. Role of the polymorphonuclear neutrophils in the phototoxic reaction in porphyria cutanea tarda.
    Pigatto P; Altomare G; Polenghi MM; Caccialanza M; Brambilla L; Finzi A
    Photodermatol; 1985 Dec; 2(6):372-6. PubMed ID: 3006001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a.
    Gerard C; Hugli TE
    Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1833-7. PubMed ID: 6940191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of C5a by phagocytic cells.
    Huber-Lang M; Younkin EM; Sarma JV; Riedemann N; McGuire SR; Lu KT; Kunkel R; Younger JG; Zetoune FS; Ward PA
    Am J Pathol; 2002 Nov; 161(5):1849-59. PubMed ID: 12414531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement activation by nylon- and polypropylene-looped prosthetic intraocular lenses.
    Tuberville AW; Galin MA; Perez HD; Banda D; Ong R; Goldstein IM
    Invest Ophthalmol Vis Sci; 1982 Jun; 22(6):727-33. PubMed ID: 7076418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complement C5a (desArg) generation in serum exposed to damaged aortic endothelium.
    Seifert PS; Catalfamo JL; Dodds WJ
    Exp Mol Pathol; 1988 Apr; 48(2):216-25. PubMed ID: 3350143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.